Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions

The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.

http://www.cardiorevascmed.com/article/S1553-8389(16)30338-4/fulltext?rss=yes

Source: Cardiovascular Revascularization Medicine - December 11, 2016 Category: Cardiology Authors: Kyle D. Buchanan, M. Chadi Alraies, Alexandre H. Kajita, Toby Rogers, Edward Koifman, Arie Steinvil Tags: Review Source Type: research